Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$16.13 - $44.61 $118,991 - $329,087
-7,377 Closed
0 $0
Q2 2022

Sep 06, 2022

SELL
$42.05 - $47.77 $21,487 - $24,410
-511 Reduced 6.48%
7,377 $321,000
Q1 2022

May 25, 2022

SELL
$40.23 - $47.74 $5,350 - $6,349
-133 Reduced 1.66%
7,888 $344,000
Q4 2021

Feb 11, 2022

SELL
$38.88 - $45.31 $92,028 - $107,248
-2,367 Reduced 22.79%
8,021 $354,000
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $13,576 - $15,105
-350 Reduced 3.26%
10,388 $397,000
Q1 2021

May 06, 2021

SELL
$34.27 - $40.01 $13,879 - $16,204
-405 Reduced 3.63%
10,738 $383,000
Q4 2020

Feb 18, 2021

BUY
$34.07 - $39.94 $1,873 - $2,196
55 Added 0.5%
11,143 $410,000
Q2 2020

Aug 05, 2020

BUY
$37.87 - $43.58 $41,202 - $47,415
1,088 Added 10.88%
11,088 $452,000
Q1 2020

Apr 29, 2020

SELL
$32.47 - $48.83 $12,988 - $19,532
-400 Reduced 3.85%
10,000 $379,000
Q4 2019

Jan 17, 2020

SELL
$42.0 - $48.25 $30,282 - $34,788
-721 Reduced 6.48%
10,400 $489,000
Q3 2019

Nov 04, 2019

BUY
$40.46 - $43.52 $15,172 - $16,320
375 Added 3.49%
11,121 $475,000
Q2 2019

Jul 10, 2019

SELL
$39.4 - $42.7 $283,680 - $307,440
-7,200 Reduced 40.12%
10,746 $430,000
Q4 2018

Jan 23, 2019

BUY
$37.8 - $42.69 $678,358 - $766,114
17,946 New
17,946 $685,000
Q4 2018

Jan 22, 2019

SELL
$37.8 - $42.69 $678,358 - $766,114
-17,946 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$39.75 - $42.69 $27,427 - $29,456
-690 Reduced 3.7%
17,946 $721,000
Q2 2018

Jul 12, 2018

BUY
$39.61 - $42.76 $27,330 - $29,504
690 Added 3.84%
18,636 $751,000
Q1 2018

May 03, 2018

SELL
$36.18 - $40.15 $10,854 - $12,045
-300 Reduced 1.64%
17,946 $701,000
Q4 2017

Feb 05, 2018

BUY
$35.34 - $41.9 $644,813 - $764,507
18,246
18,246 $647,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $71.7B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track First National Bank Of Omaha Portfolio

Follow First National Bank Of Omaha and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.